The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Steffan T. Nawrocki; Yingchun Han; Valeria Visconte; Bartlomiej Przychodzen; Claudia M. Espitia; James Phillips; Faiz Anwer; Anjali Advani; Hetty E. Carraway; Kevin R. Kelly; Mikkael A. Sekeres; Jaroslaw P. Maciejewski; Jennifer S. Carew

doi:10.1038/s41375-019-0529-2

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Steffan T. Nawrocki, Yingchun Han, Valeria Visconte, Bartlomiej Przychodzen, Claudia M. Espitia, James Phillips, Faiz Anwer, Anjali Advani, Hetty E. Carraway, Kevin R. Kelly, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew

Medicine

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Original language	English (US)
Pages (from-to)	2971-2974
Number of pages	4
Journal	Leukemia
Volume	33
Issue number	12
DOIs	https://doi.org/10.1038/s41375-019-0529-2
State	Published - Dec 1 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-019-0529-2

Cite this

@article{628cacaae6784cbdbb76210c325f805e,

title = "The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine",

author = "Nawrocki, {Steffan T.} and Yingchun Han and Valeria Visconte and Bartlomiej Przychodzen and Espitia, {Claudia M.} and James Phillips and Faiz Anwer and Anjali Advani and Carraway, {Hetty E.} and Kelly, {Kevin R.} and Sekeres, {Mikkael A.} and Maciejewski, {Jaroslaw P.} and Carew, {Jennifer S.}",

note = "Funding Information: Acknowledgements This project was supported by grants from the National Cancer Institute (R01CA172443 to JSC and R01CA190789 to STN) and the University of Arizona Cancer Center Support Grant P30CA023074.",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41375-019-0529-2",

language = "English (US)",

volume = "33",

pages = "2971--2974",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

AU - Nawrocki, Steffan T.

AU - Han, Yingchun

AU - Visconte, Valeria

AU - Przychodzen, Bartlomiej

AU - Espitia, Claudia M.

AU - Phillips, James

AU - Anwer, Faiz

AU - Advani, Anjali

AU - Carraway, Hetty E.

AU - Kelly, Kevin R.

AU - Sekeres, Mikkael A.

AU - Maciejewski, Jaroslaw P.

AU - Carew, Jennifer S.

N1 - Funding Information: Acknowledgements This project was supported by grants from the National Cancer Institute (R01CA172443 to JSC and R01CA190789 to STN) and the University of Arizona Cancer Center Support Grant P30CA023074.

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85069939537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069939537&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0529-2

DO - 10.1038/s41375-019-0529-2

M3 - Letter

C2 - 31358855

AN - SCOPUS:85069939537

SN - 0887-6924

VL - 33

SP - 2971

EP - 2974

JO - Leukemia

JF - Leukemia

IS - 12

ER -

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this